Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine.

Slovin SF, Ragupathi G, Musselli C, Olkiewicz K, Verbel D, Kuduk SD, Schwarz JB, Sames D, Danishefsky S, Livingston PO, Scher HI.

J Clin Oncol. 2003 Dec 1;21(23):4292-8.

PMID:
14645418
[PubMed - indexed for MEDLINE]
2.
3.

Carbohydrate vaccines as immunotherapy for cancer.

Slovin SF, Keding SJ, Ragupathi G.

Immunol Cell Biol. 2005 Aug;83(4):418-28. Review.

PMID:
16033538
[PubMed - indexed for MEDLINE]
4.

Rationale for the clinical development of STn-KLH (Theratope) and anti-MUC-1 vaccines in breast cancer.

Miles D, Papazisis K.

Clin Breast Cancer. 2003 Feb;3 Suppl 4:S134-8. Review.

PMID:
12620150
[PubMed - indexed for MEDLINE]
5.

DNA vaccines: an active immunization strategy for prostate cancer.

Wolchok JD, Gregor PD, Nordquist LT, Slovin SF, Scher HI.

Semin Oncol. 2003 Oct;30(5):659-66. Review.

PMID:
14571413
[PubMed - indexed for MEDLINE]
6.

Vaccines as treatment strategies for relapsed prostate cancer: approaches for induction of immunity.

Slovin SF.

Hematol Oncol Clin North Am. 2001 Jun;15(3):477-96. Review.

PMID:
11525292
[PubMed - indexed for MEDLINE]
7.

Theratope vaccine (STn-KLH).

Holmberg LA, Sandmaier BM.

Expert Opin Biol Ther. 2001 Sep;1(5):881-91. Review.

PMID:
11728222
[PubMed - indexed for MEDLINE]
8.

Synthetic carbohydrate-based antitumor vaccines: challenges and opportunities.

Ouerfelli O, Warren JD, Wilson RM, Danishefsky SJ.

Expert Rev Vaccines. 2005 Oct;4(5):677-85. Review.

PMID:
16221069
[PubMed - indexed for MEDLINE]
9.

Clinical development of the STn-KLH vaccine (Theratope).

Ibrahim NK, Murray JL.

Clin Breast Cancer. 2003 Feb;3 Suppl 4:S139-43. Review.

PMID:
12620151
[PubMed - indexed for MEDLINE]
10.

Carbohydrate antigens as targets for active specific immunotherapy.

Ragupathi G.

Cancer Immunol Immunother. 1996 Nov;43(3):152-7. Review.

PMID:
9001568
[PubMed - indexed for MEDLINE]
11.

The use of carbohydrate antigens for the preparation of vaccines for therapy in breast cancer.

Croce MV, Segal-Eiras A.

Drugs Today (Barc). 2002 Nov;38(11):759-68. Review.

PMID:
12582459
[PubMed - indexed for MEDLINE]
12.

Current vaccination strategies for prostate cancer.

Joniau S, Abrahamsson PA, Bellmunt J, Figdor C, Hamdy F, Verhagen P, Vogelzang NJ, Wirth M, Van Poppel H, Osanto S.

Eur Urol. 2012 Feb;61(2):290-306. doi: 10.1016/j.eururo.2011.09.020. Epub 2011 Oct 3. Review.

PMID:
22001436
[PubMed - indexed for MEDLINE]
13.

Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines.

Hakomori S.

Adv Exp Med Biol. 2001;491:369-402. Review.

PMID:
14533809
[PubMed - indexed for MEDLINE]
14.

Immunotherapy for cancer: synthetic carbohydrate-based vaccines.

Buskas T, Thompson P, Boons GJ.

Chem Commun (Camb). 2009 Sep 28;(36):5335-49. doi: 10.1039/b908664c. Epub 2009 Jul 22. Review.

PMID:
19724783
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Recent development in carbohydrate-based cancer vaccines.

Guo Z, Wang Q.

Curr Opin Chem Biol. 2009 Dec;13(5-6):608-17. doi: 10.1016/j.cbpa.2009.08.010. Epub 2009 Sep 18. Review.

PMID:
19766052
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Ganglioside vaccines with emphasis on GM2.

Livingston P.

Semin Oncol. 1998 Dec;25(6):636-45. Review.

PMID:
9865678
[PubMed - indexed for MEDLINE]
17.

Synthetic carbohydrate-based anticancer vaccines: the Memorial Sloan-Kettering experience.

Zhu J, Warren JD, Danishefsky SJ.

Expert Rev Vaccines. 2009 Oct;8(10):1399-413. doi: 10.1586/erv.09.95. Review.

PMID:
19803761
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The Tn antigen-structural simplicity and biological complexity.

Ju T, Otto VI, Cummings RD.

Angew Chem Int Ed Engl. 2011 Feb 18;50(8):1770-91. doi: 10.1002/anie.201002313. Epub 2011 Jan 21. Review.

PMID:
21259410
[PubMed - indexed for MEDLINE]
19.

Carrier protein conjugate vaccines: the "missing link" to improved antibody and CTL responses?

Timmerman JM.

Hum Vaccin. 2009 Mar;5(3):181-3. Epub 2009 Mar 24. Review.

PMID:
19246995
[PubMed - indexed for MEDLINE]
Free Article
20.

Vaccine therapy for small cell lung cancer.

Krug LM.

Semin Oncol. 2004 Feb;31(1 Suppl 1):112-6. Review.

PMID:
14981589
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk